Filing Details

Accession Number:
0000950170-24-116360
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2024-10-22 17:31:39
Reporting Period:
2024-10-15
Accepted Time:
2024-10-22 17:31:39
Original Submission Date:
2024-10-15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1736730 Camp4 Therapeutics Corp CAMP () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1295675 Brian Chee One Marina Park Drive, 8Th Floor
Boston MA 02210
No No No No
1438226 W Amy Schulman One Marina Park Drive, 8Th Floor
Boston MA 02210
No No No No
1611189 Polaris Partners Vii, L.p. One Marina Park Drive, 8Th Floor
Boston MA 02210
No No No No
1615991 Polaris Entrepreneurs' Fund Vii, L.p. One Marina Park Drive
8Th Floor
Boston MA 02210
No No No No
1678203 Polaris Management Co. Vii, L.l.c. One Marina Park Drive, 8Th Floor
Boston MA 02210
No No No No
1910575 Polaris Partners Gp X, L.l.c. One Marina Park Drive, 8Th Floor
Boston MA 02210
No No No No
1910577 Polaris Partners X, L.p. One Marina Park Drive, 8Th Floor
Boston MA 02210
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-10-15 1,250,061 $0.00 1,250,061 No 4 C Indirect See footnote
Common Stock Acquisiton 2024-10-15 87,448 $0.00 87,448 No 4 C Indirect See footnote
Common Stock Acquisiton 2024-10-15 353,718 $0.00 1,603,779 No 4 C Indirect See footnote
Common Stock Acquisiton 2024-10-15 24,745 $0.00 112,193 No 4 C Indirect See footnote
Common Stock Acquisiton 2024-10-15 909,090 $11.00 909,090 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 C Indirect See footnote
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Prime Preferred Stock Disposition 2024-10-15 14,020,475 $0.00 1,250,061 $0.00
Common Stock Series A Prime Preferred Stock Disposition 2024-10-15 980,829 $0.00 87,448 $0.00
Common Stock Series B Preferred Stock Disposition 2024-10-15 3,967,234 $0.00 353,718 $0.00
Common Stock Series B Preferred Stock Disposition 2024-10-15 277,536 $0.00 24,745 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. On October 15, 2024, the shares of Series A Prime Convertible Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
  2. The reported securities are owned directly by Polaris Partners VII, L.P. ("PP VII"). Polaris Management Co. VII, L.L.C. ("PMC VII") is the general partner of PP VII. Each of David Barrett, Brian Chee, Amir Nashat, a member of the Issuer's board of directors, and Bryce Youngren (collectively, the "PMC VII Managing Members") are the managing members of PMC VII. Each of PMC VII and the PMC VII Managing Members in their respective capacities with respect to PMC VII, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PP VII. Each of PMC VII and the PMC VII Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the PMC VII Managing Members or PMC VII is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
  3. The reported securities are owned directly by Polaris Entrepreneurs' Fund VII, L.P. ("PEF VII"). PMC VII is the general partner of PEF VII. Each of PMC VII and the PMC VII Managing Members in their respective capacities with respect to PMC VII, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PEF VII. Each of PMC VII and the PMC VII Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the PMC VII Managing Members or PMC VII is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
  4. On October 15, 2024, the shares of Series B Preferred Stock automatically converted into shares of Common Stock on a 11.2158-for-one basis without payment of further consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date.
  5. The reported securities are owned directly by Polaris Partners X, L.P. ("PP X"). Polaris Partners GP X, L.L.C. ("PPGP X") is the general partner of PP X. Each of Amy Schulman and Brian Chee are the managing members of PPGP X (the "PPGP X Managing Members"). Amir Nashat ("Mr. Nashat"), a member of the Issuer's board of directors, is an interest holder of PPGP X. Each of PPGP X, the PPGP X Managing Members and Mr. Nashat, in their respective capacities with respect to PPGP X, may be deemed to have shared voting, investment and dispositive power with respect to the securities held by PP X. Each of PPGP X, the PPGP X Managing Members and Mr. Nashat disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of the PPGP X Managing Members, Mr. Nashat or PPGP X is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.